Your browser doesn't support javascript.
loading
Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients.
Marcq, Elly; Waele, Jorrit De; Audenaerde, Jonas Van; Lion, Eva; Santermans, Eva; Hens, Niel; Pauwels, Patrick; van Meerbeeck, Jan P; Smits, Evelien L J.
Afiliação
  • Marcq E; Center for Oncological Research, University of Antwerp, Antwerp, Belgium.
  • Waele J; Center for Oncological Research, University of Antwerp, Antwerp, Belgium.
  • Audenaerde JV; Center for Oncological Research, University of Antwerp, Antwerp, Belgium.
  • Lion E; Laboratory of Experimental Hematology, University of Antwerp, Antwerp, Belgium.
  • Santermans E; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Diepenbeek, Belgium.
  • Hens N; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Hasselt University, Diepenbeek, Belgium.
  • Pauwels P; Center for Health Economics Research and Modelling Infectious Diseases, University of Antwerp, Antwerp, Belgium.
  • van Meerbeeck JP; Center for Oncological Research, University of Antwerp, Antwerp, Belgium.
  • Smits ELJ; Department of Pathology, Antwerp University Hospital, Antwerp, Belgium.
Oncotarget ; 8(52): 89722-89735, 2017 Oct 27.
Article em En | MEDLINE | ID: mdl-29163783
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article